Lexicor Medical Technologies Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Lexicor Medical Technologies Inc.
Regulatory Briefs: FDA Device Reclassifications, Meetings Announcements
FDA proposes class II for nonthermal shortwave therapy devices and updates regulations to reflect class II designation for neuropsychiatric assessment device. Meetings on manufacturing quality, clinical trials and medical countermeasures announced. More regulatory news.
Company Information
- Industry
- Biotechnology
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice